Teva Can't Nix Bristol-Myers' Eliquis Patent At The Hague
A Dutch court has chucked Teva's bid to end Bristol-Myers Squibb's extended protections over blood clot treatment Eliquis in the Netherlands, ruling Wednesday that its now-expired patent was always valid....To view the full article, register now.
Already a subscriber? Click here to view full article